コンパニオンアニマル向け変形性関節症の世界市場、規模、シェア、動向、産業分析レポート：動物別、製品別、投与経路別、最終用途別、地域別 - 市場予測、2025年～2034年

Polaris Market Research社の最新調査によると、コンパニオンアニマル向け変形性関節症市場規模は2034年までに184億5,000万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

コンパニオンアニマル向け変形性関節症市場は、ペット、特に犬や猫の退行性関節疾患を対象とした医療ソリューションに対する需要の高まりに対応しています。慢性かつ進行性の疾患である変形性関節症は、高齢化した動物における運動能力の低下や痛みの主な原因となっています。ペットの飼い主の意識の高まり、獣医師による診察の増加、診断能力の向上により、市場は勢いを増しています。成長を支えているのは、治療のコンプライアンスとペットの生活の質を高める長時間作用型の注射薬や抗炎症薬などの医薬品製剤の進歩です。

獣医師は、炎症を管理し関節修復を促進するために、多血小板血漿（PRP）や幹細胞応用などの再生療法を統合しています。早期介入と多方面からの疼痛管理が重視されるようになり、薬物、栄養補助食品、身体リハビリテーションを含む併用療法の開発に影響を与えています。市場参入企業は、様々なリスクプロファイルに対応する非侵襲的な選択肢や犬種に特化したソリューションを求める需要に応えています。活動レベルや可動性をモニターするデジタルツールは、より良い治療追跡や介護者の関与を可能にする支援技術として台頭してきています。予防医療、特に関節の健康サプリメントやシニアペット向けのウェルネスプランの開発には、引き続きビジネスチャンスが広がっています。ペットのヒューマニゼーション（人間化）の動向の高まりは、メーカーに安全性、嗜好性、エビデンスに基づく有効性を優先するよう促しています。進化する獣医学的ガイドラインと獣医診療所と製薬会社の協力が、製品の革新と臨床採用を促進しています。

コンパニオンアニマル向け変形性関節症市場レポートハイライト

製品別では、生物学的製剤セグメントは、単に症状を緩和するだけでなく、変形性関節症の根本的な原因をターゲットにする能力があるため、2024年の売上シェアの～54%を占めました。

動物別では、特に高齢の大型動物で変形性関節症の発生率が高いため、2024年には犬セグメントが最大の収益シェアを占めました。

2024年には、ペットの医療支出の高さ、高度な獣医学的インフラ、コンパニオンアニマルの慢性関節疾患に対する強い認識により、北米が最大の収益シェアを占めました。

アジア太平洋のコンパニオンアニマル向け変形性関節症市場は、ペット飼育の増加、中間所得層の所得拡大、動物の健康に対する意識の高まりにより、2025年から2034年にかけて大きく成長すると予想されています。

世界の主要企業には、Boehringer Ingelheim International GmbH, Ceva, Dechra Pharmaceuticals PLC., Elanco, Eltech K-Laser s.r.l., NexGen Pharmaceuticals, Norbrook, Vetoquinol, Virbac, Zoetisなどがあります。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 コンパニオンアニマル向け変形性関節症市場の洞察

• 市場スナップショット
• コンパニオンアニマル向け変形性関節症市場力学
  • 促進要因と機会
    • ペット飼育の増加と人間化
    • 獣医整形外科治療の成長
  • 抑制要因と課題
    • 高額な治療費
• PESTEL分析
• コンパニオンアニマル向け変形性関節症市場パワー評価の動向
• バリューチェーン分析

第5章 コンパニオンアニマル向け変形性関節症市場：製品別

• 主な調査結果
• イントロダクション
• 生物学的製剤
• 粘性サプリメント
• 医薬品
• 栄養補助食品

第6章 コンパニオンアニマル向け変形性関節症市場：動物別

• 主な調査結果
• イントロダクション
• 犬
• 馬
• 猫
• その他

第7章 コンパニオンアニマル向け変形性関節症市場：投与経路別

• 主な調査結果
• イントロダクション
• 経口
• 注射
• その他

第8章 コンパニオンアニマル向け変形性関節症市場：最終用途別

• 主な調査結果
• イントロダクション
• 動物病院/クリニック
• eコマース
• その他

第9章 コンパニオンアニマル向け変形性関節症市場：地域別

• 主な調査結果
• イントロダクション
  • コンパニオンアニマル向け変形性関節症市場分析：地域別、2020年～2034年
• 北米
  • 北米：製品別、2020～2034年
  • 北米：動物別、2020～2034年
  • 北米：最終用途別、2020～2034年
  • 北米：投与経路別、2020～2034年
  • 米国
  • カナダ
• 欧州
  • 欧州：製品別、2020～2034年
  • 欧州：動物別、2020～2034年
  • 欧州：最終用途別、2020～2034年
  • 欧州：投与経路別、2020～2034年
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • オランダ
  • ロシア
  • その他欧州
• アジア太平洋地域
  • アジア太平洋地域：製品別、2020～2034年
  • アジア太平洋地域：動物別、2020～2034年
  • アジア太平洋地域：最終用途別、2020～2034年
  • アジア太平洋地域：投与経路別、2020～2034年
  • 中国
  • インド
  • マレーシア
  • 日本
  • インドネシア
  • 韓国
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ
  • 中東・アフリカ：製品別、2020～2034年
  • 中東・アフリカ：動物別、2020～2034年
  • 中東・アフリカ：最終用途別、2020～2034年
  • 中東・アフリカ：投与経路別、2020～2034年
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東・アフリカ
• ラテンアメリカ
  • ラテンアメリカ：製品別、2020～2034年
  • ラテンアメリカ：動物別、2020～2034年
  • ラテンアメリカ：最終用途別、2020～2034年
  • ラテンアメリカ：投与経路別、2020～2034年
  • メキシコ
  • ブラジル
  • アルゼンチン
  • その他ラテンアメリカ

第10章 競合情勢

• 拡大と買収の分析
  • 拡大
  • 買収
• 提携/協業/合意/公開

第11章 企業プロファイル

• Boehringer Ingelheim International GmbH
• Ceva
• Dechra Pharmaceuticals PLC.
• Elanco
• Eltech K-Laser s.r.l.
• NexGen Pharmaceuticals
• Norbrook
• Vetoquinol
• Virbac
• Zoetis

List of Tables:

• Table 1 Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 2 Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 3 Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 4 Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 5 North America: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 6 North America: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 7 North America: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 8 North America: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 9 US: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 10 US: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 11 US: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 12 US: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 13 Canada: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 14 Canada: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 15 Canada: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 16 Canada: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 17 Europe: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 18 Europe: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 19 Europe: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 20 Europe: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 21 UK: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 22 UK: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 23 UK: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 24 UK: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 25 France: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 26 France: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 27 France: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 28 France: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 29 Germany: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 30 Germany: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 31 Germany: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 32 Germany: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 33 Italy: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 34 Italy: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 35 Italy: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 36 Italy: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 37 Spain: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 38 Spain: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 39 Spain: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 40 Spain: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 41 Netherlands: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 42 Netherlands: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 43 Netherlands: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 44 Netherlands: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 45 Russia: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 46 Russia: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 47 Russia: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 48 Russia: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 49 Rest of Europe: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 50 Rest of Europe: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 51 Rest of Europe: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 52 Rest of Europe: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 53 Asia Pacific: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 54 Asia Pacific: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 55 Asia Pacific: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 56 Asia Pacific: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 57 China: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 58 China: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 59 China: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 60 China: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 61 India: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 62 India: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 63 India: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 64 India: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 65 Malaysia: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 66 Malaysia: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 67 Malaysia: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 68 Malaysia: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 69 Japan: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 70 Japan: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 71 Japan: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 72 Japan: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 73 Indonesia: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 74 Indonesia: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 75 Indonesia: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 76 Indonesia: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 77 South Korea: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 78 South Korea: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 79 South Korea: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 80 South Korea: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 81 Australia: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 82 Australia: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 83 Australia: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 84 Australia: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 85 Rest of Asia Pacific: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 86 Rest of Asia Pacific: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 87 Rest of Asia Pacific: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 88 Rest of Asia Pacific: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 89 Middle East & Africa: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 90 Middle East & Africa: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 91 Middle East & Africa: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 92 Middle East & Africa: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 93 Saudi Arabia: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 94 Saudi Arabia: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 95 Saudi Arabia: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 96 Saudi Arabia: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 97 UAE: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 98 UAE: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 99 UAE: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 100 UAE: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 101 Israel: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 102 Israel: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 103 Israel: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 104 Israel: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 105 South Africa: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 106 South Africa: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 107 South Africa: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 108 South Africa: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 109 Rest of Middle East & Africa: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 110 Rest of Middle East & Africa: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 111 Rest of Middle East & Africa: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 112 Rest of Middle East & Africa: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 113 Latin America: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 114 Latin America: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 115 Latin America: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 116 Latin America: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 117 Mexico: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 118 Mexico: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 119 Mexico: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 120 Mexico: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 121 Brazil: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 122 Brazil: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 123 Brazil: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 124 Brazil: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 125 Argentina: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 126 Argentina: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 127 Argentina: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 128 Argentina: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 129 Rest of Latin America: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
• Table 130 Rest of Latin America: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• Table 131 Rest of Latin America: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• Table 132 Rest of Latin America: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)

List of Figures:

• Figure 1. Companion Animal Osteoarthritis Market, 2020-2034 (USD Billion)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Price
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Product
• Figure 7. Companion Animal Osteoarthritis Market, By Product, 2024 & 2034 (USD Billion)
• Figure 8. Market by Animal
• Figure 9. Companion Animal Osteoarthritis Market, By Animal, 2024 & 2034 (USD Billion)
• Figure 10. Market by End Use
• Figure 11. Companion Animal Osteoarthritis Market, by End Use, 2024 & 2034 (USD Billion)
• Figure 12. Market by Route of Administration
• Figure 13. Companion Animal Osteoarthritis Market, by Route of Administration, 2024 & 2034 (USD Billion)

The companion animal osteoarthritis market size is expected to reach USD 18.45 billion by 2034, according to a new study by Polaris Market Research. The report "Companion Animal Osteoarthritis Market Size, Share, Trend, Industry Analysis Report By Animal (Canine, Equine, Feline), By Product, By Route of Administration, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The companion animal osteoarthritis market addresses the growing demand for medical solutions targeting degenerative joint conditions in pets, particularly dogs and cats. Osteoarthritis, a chronic and progressive disease, is a leading cause of mobility loss and pain in aging animals. The market is gaining momentum due to increasing awareness among pet owners, a rise in veterinary consultations, and improved diagnostic capabilities. Growth is supported by advancements in pharmaceutical formulations, including long-acting injectable and anti-inflammatory medications that enhance treatment compliance and quality of life for pets.

Veterinarians are integrating regenerative therapies such as platelet-rich plasma (PRP) and stem cell applications to manage inflammation and promote joint repair. Increasing emphasis on early intervention and multimodal pain management is influencing the development of combination therapies involving drugs, dietary supplements, and physical rehabilitation. Market participants are responding to demand for noninvasive options and breed-specific solutions that address varying risk profiles. Digital tools for monitoring activity levels and mobility are emerging as supportive technologies, enabling better treatment tracking and caregiver engagement. Opportunities continue to grow in preventive care, particularly in the development of joint health supplements and wellness plans for senior pets. The rising trend of pet humanization is pushing manufacturers to prioritize safety, palatability, and evidence-based efficacy. Evolving veterinary guidelines and collaboration between veterinary practices and pharmaceutical companies are driving product innovation and clinical adoption.

Companion Animal Osteoarthritis Market Report Highlights

By product, the biologics segment accounted for ~54% of the revenue share in 2024 due to their ability to target the underlying causes of osteoarthritis rather than just alleviating symptoms.

Based on animal, the canine segment held the largest revenue share in 2024 due to the high incidence of osteoarthritis, particularly in aging and large-breed animals.

In 2024, North America accounted for the largest revenue share due to high pet healthcare spending, advanced veterinary infrastructure, and strong awareness of chronic joint conditions in companion animals.

The Asia Pacific companion animal osteoarthritis market is expected to grow significantly from 2025 to 2034 due to rising pet adoption, expanding middle-class income, and increasing awareness of animal health.

A few global key players include Boehringer Ingelheim International GmbH, Ceva, Dechra Pharmaceuticals PLC., Elanco, Eltech K-Laser s.r.l., NexGen Pharmaceuticals, Norbrook, Vetoquinol, Virbac, and Zoetis.

Polaris Market Research has segmented the companion animal osteoarthritis market report on the basis of product, animal, route of administration, end use, and region:

By Product Outlook (Revenue, USD Billion, 2020-2034)

Biologics

Stem Cells

Platelet-Rich Plasma (PRP)

Monoclonal Antibodies (mAb)

Other Biologics

Viscosupplements

Pharmaceuticals

Steroids

NSAIDS

Others

Nutritional Supplements

By Animal Outlook (Revenue, USD Billion, 2020-2034)

Canine

Equine

Feline

By Route of Administration Outlook (Revenue, USD Billion, 2020-2034)

Oral

Injectable

Others

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Veterinary Hospitals/Clinics

E-commerce

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Companion Animal Osteoarthritis Market Insights

• 4.1. Companion Animal Osteoarthritis Market - Market Snapshot
• 4.2. Companion Animal Osteoarthritis Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Increased Pet Ownership and Humanization
    • 4.2.1.2. Growth in Veterinary Orthopaedic Treatments
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. High treatment costs
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Companion Animal Osteoarthritis Market Power Rating Trends
• 4.6. Value Chain Analysis

5. Companion Animal Osteoarthritis Market, by Product

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Companion Animal Osteoarthritis Market, by Product, 2020-2034 (USD Billion)
• 5.3. Biologics
  • 5.3.1. Companion Animal Osteoarthritis Market, by Biologics, by Region, 2020-2034 (USD Billion)
  • 5.3.2. Stem Cells
    • 5.3.2.1. Companion Animal Osteoarthritis Market, by Stem Cells, by Region, 2020-2034 (USD Billion)
  • 5.3.3. Platelet-Rich Plasma (PRP)
    • 5.3.3.1. Companion Animal Osteoarthritis Market, by Platelet-Rich Plasma (PRP), by Region, 2020-2034 (USD Billion)
  • 5.3.4. Monoclonal Antibodies (mAb)
    • 5.3.4.1. Companion Animal Osteoarthritis Market, by Monoclonal Antibodies (mAb), by Region, 2020-2034 (USD Billion)
  • 5.3.5. Other Biologics
    • 5.3.5.1. Companion Animal Osteoarthritis Market, by Other Biologics, by Region, 2020-2034 (USD Billion)
• 5.4. Viscosupplements
  • 5.4.1. Companion Animal Osteoarthritis Market, by Viscosupplements, by Region, 2020-2034 (USD Billion)
• 5.5. Pharmaceuticals
  • 5.5.1. Companion Animal Osteoarthritis Market, by Pharmaceuticals, by Region, 2020-2034 (USD Billion)
  • 5.5.2. Steroids
    • 5.5.2.1. Companion Animal Osteoarthritis Market, by Steroids, by Region, 2020-2034 (USD Billion)
  • 5.5.3. NSAIDS
    • 5.5.3.1. Companion Animal Osteoarthritis Market, by NSAIDS, by Region, 2020-2034 (USD Billion)
  • 5.5.4. Others
    • 5.5.4.1. Companion Animal Osteoarthritis Market, by Others, by Region, 2020-2034 (USD Billion)
• 5.6. Nutritional Supplements
  • 5.6.1. Companion Animal Osteoarthritis Market, by Others, by Region, 2020-2034 (USD Billion)

6. Companion Animal Osteoarthritis Market, by Animal

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
• 6.3. Canine
  • 6.3.1. Companion Animal Osteoarthritis Market, by Canine, by Region, 2020-2034 (USD Billion)
• 6.4. Equine
  • 6.4.1. Companion Animal Osteoarthritis Market, by Equine, by Region, 2020-2034 (USD Billion)
• 6.5. Feline
  • 6.5.1. Companion Animal Osteoarthritis Market, by Feline, by Region, 2020-2034 (USD Billion)
• 6.6. Others
  • 6.6.1. Companion Animal Osteoarthritis Market, by Others, by Region, 2020-2034 (USD Billion)

7. Companion Animal Osteoarthritis Market, by Route of Administration

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• 7.3. Oral
  • 7.3.1. Companion Animal Osteoarthritis Market, by Oral, by Region, 2020-2034 (USD Billion)
• 7.4. Injectable
  • 7.4.1. Companion Animal Osteoarthritis Market, by Injectable, by Region, 2020-2034 (USD Billion)
• 7.5. Others
  • 7.5.1. Companion Animal Osteoarthritis Market, by Others, by Region, 2020-2034 (USD Billion)

8. Companion Animal Osteoarthritis Market, by End Use

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
• 8.3. Veterinary Hospitals/Clinics
  • 8.3.1. Companion Animal Osteoarthritis Market, by Veterinary Hospitals/Clinics, by Region, 2020-2034 (USD Billion)
• 8.4. E-commerce
  • 8.4.1. Companion Animal Osteoarthritis Market, by E-commerce, by Region, 2020-2034 (USD Billion)
• 8.5. Others
  • 8.5.1. Companion Animal Osteoarthritis Market, by Others, by Region, 2020-2034 (USD Billion)

9. Companion Animal Osteoarthritis Market, by Geography

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Companion Animal Osteoarthritis Market Assessment, By Geography, 2020-2034 (USD Billion)
• 9.3. Companion Animal Osteoarthritis Market - North America
  • 9.3.1. North America: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • 9.3.2. North America: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • 9.3.3. North America: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • 9.3.4. North America: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.3.5. Companion Animal Osteoarthritis Market - US
    • 9.3.5.1. US: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.3.5.2. US: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.3.5.3. US: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.3.5.4. US: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.3.6. Companion Animal Osteoarthritis Market - Canada
    • 9.3.6.1. Canada: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.3.6.2. Canada: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.3.6.3. Canada: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.3.6.4. Canada: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• 9.4. Companion Animal Osteoarthritis Market - Europe
  • 9.4.1. Europe: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • 9.4.2. Europe: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • 9.4.3. Europe: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • 9.4.4. Europe: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.4.5. Companion Animal Osteoarthritis Market - UK
    • 9.4.5.1. UK: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.4.5.2. UK: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.4.5.3. UK: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.5.4. UK: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.4.6. Companion Animal Osteoarthritis Market - France
    • 9.4.6.1. France: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.4.6.2. France: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.4.6.3. France: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.6.4. France: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.4.7. Companion Animal Osteoarthritis Market - Germany
    • 9.4.7.1. Germany: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.4.7.2. Germany: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.4.7.3. Germany: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.7.4. Germany: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.4.8. Companion Animal Osteoarthritis Market - Italy
    • 9.4.8.1. Italy: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.4.8.2. Italy: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.4.8.3. Italy: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.8.4. Italy: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.4.9. Companion Animal Osteoarthritis Market - Spain
    • 9.4.9.1. Spain: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.4.9.2. Spain: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.4.9.3. Spain: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.9.4. Spain: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.4.10. Companion Animal Osteoarthritis Market - Netherlands
    • 9.4.10.1. Netherlands: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.4.10.2. Netherlands: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.4.10.3. Netherlands: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.10.4. Netherlands: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.4.11. Companion Animal Osteoarthritis Market - Russia
    • 9.4.11.1. Russia: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.4.11.2. Russia: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.4.11.3. Russia: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.11.4. Russia: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.4.12. Companion Animal Osteoarthritis Market - Rest of Europe
    • 9.4.12.1. Rest of Europe: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.4.12.2. Rest of Europe: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.4.12.3. Rest of Europe: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.12.4. Rest of Europe: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• 9.5. Companion Animal Osteoarthritis Market - Asia Pacific
  • 9.5.1. Asia Pacific: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • 9.5.2. Asia Pacific: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • 9.5.3. Asia Pacific: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • 9.5.4. Asia Pacific: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.5.5. Companion Animal Osteoarthritis Market - China
    • 9.5.5.1. China: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.5.5.2. China: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.5.5.3. China: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.5.4. China: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.5.6. Companion Animal Osteoarthritis Market - India
    • 9.5.6.1. India: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.5.6.2. India: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.5.6.3. India: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.6.4. India: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.5.7. Companion Animal Osteoarthritis Market - Malaysia
    • 9.5.7.1. Malaysia: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.5.7.2. Malaysia: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.5.7.3. Malaysia: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.7.4. Malaysia: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.5.8. Companion Animal Osteoarthritis Market - Japan
    • 9.5.8.1. Japan: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.5.8.2. Japan: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.5.8.3. Japan: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.8.4. Japan: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.5.9. Companion Animal Osteoarthritis Market - Indonesia
    • 9.5.9.1. Indonesia: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.5.9.2. Indonesia: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.5.9.3. Indonesia: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.9.4. Indonesia: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.5.10. Companion Animal Osteoarthritis Market - South Korea
    • 9.5.10.1. South Korea: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.5.10.2. South Korea: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.5.10.3. South Korea: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.10.4. South Korea: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.5.11. Companion Animal Osteoarthritis Market - Australia
    • 9.5.11.1. Australia: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.5.11.2. Australia: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.5.11.3. Australia: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.11.4. Australia: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.5.12. Companion Animal Osteoarthritis Market - Rest of Asia Pacific
    • 9.5.12.1. Rest of Asia Pacific: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.5.12.2. Rest of Asia Pacific: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.5.12.3. Rest of Asia Pacific: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.12.4. Rest of Asia Pacific: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• 9.6. Companion Animal Osteoarthritis Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • 9.6.2. Middle East & Africa: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • 9.6.3. Middle East & Africa: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • 9.6.4. Middle East & Africa: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.6.5. Companion Animal Osteoarthritis Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.6.5.2. Saudi Arabia: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.6.5.3. Saudi Arabia: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.5.4. Saudi Arabia: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.6.6. Companion Animal Osteoarthritis Market - UAE
    • 9.6.6.1. UAE: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.6.6.2. UAE: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.6.6.3. UAE: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.6.4. UAE: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.6.7. Companion Animal Osteoarthritis Market - Israel
    • 9.6.7.1. Israel: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.6.7.2. Israel: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.6.7.3. Israel: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.7.4. Israel: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.6.8. Companion Animal Osteoarthritis Market - South Africa
    • 9.6.8.1. South Africa: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.6.8.2. South Africa: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.6.8.3. South Africa: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.8.4. South Africa: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.6.9. Companion Animal Osteoarthritis Market - Rest of Middle East & Africa
    • 9.6.9.1. Rest of Middle East & Africa: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.6.9.2. Rest of Middle East & Africa: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.6.9.3. Rest of Middle East & Africa: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.9.4. Rest of Middle East & Africa: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
• 9.7. Companion Animal Osteoarthritis Market - Latin America
  • 9.7.1. Latin America: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
  • 9.7.2. Latin America: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
  • 9.7.3. Latin America: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
  • 9.7.4. Latin America: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.7.5. Companion Animal Osteoarthritis Market - Mexico
    • 9.7.5.1. Mexico: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.7.5.2. Mexico: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.7.5.3. Mexico: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.5.4. Mexico: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.7.6. Companion Animal Osteoarthritis Market - Brazil
    • 9.7.6.1. Brazil: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.7.6.2. Brazil: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.7.6.3. Brazil: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.6.4. Brazil: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.7.7. Companion Animal Osteoarthritis Market - Argentina
    • 9.7.7.1. Argentina: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.7.7.2. Argentina: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.7.7.3. Argentina: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.7.4. Argentina: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.7.8. Companion Animal Osteoarthritis Market - Rest of Latin America
    • 9.7.8.1. Rest of Latin America: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
    • 9.7.8.2. Rest of Latin America: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
    • 9.7.8.3. Rest of Latin America: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.8.4. Rest of Latin America: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Boehringer Ingelheim International GmbH
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Ceva
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. Dechra Pharmaceuticals PLC.
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. Elanco
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. Eltech K-Laser s.r.l.
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. NexGen Pharmaceuticals
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. Norbrook
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. Vetoquinol
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. Virbac
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. Zoetis
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development